New Drug Shows Potential to Treat the Resistanat Strain of Malaria
A new drug, Ganaplacide can clear malaria infection including strains that are resistant to the currently commonly used Artemisinin- based Therapies -ACTs, a new study done in seven malaria endemic countries including Uganda has shown. According to a statement by Novartis, a Swiss pharmaceutical company that manufactures the widely used antimalarial drug Coartem, the new…